bioAffinity Technologies (BIAF) Operating Income (2022 - 2025)
Historic Operating Income for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$2.3 million.
- bioAffinity Technologies' Operating Income fell 1616.03% to -$2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.4 million, marking a year-over-year decrease of 2434.7%. This contributed to the annual value of -$9.0 million for FY2024, which is 1229.39% down from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' Operating Income is -$2.3 million, which was down 1616.03% from -$2.5 million recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Operating Income ranged from a high of -$684119.0 in Q2 2022 and a low of -$2.9 million during Q4 2024
- Its 4-year average for Operating Income is -$1.9 million, with a median of -$2.0 million in 2024.
- Its Operating Income has fluctuated over the past 5 years, first plummeted by 15994.75% in 2023, then surged by 1397.43% in 2024.
- bioAffinity Technologies' Operating Income (Quarter) stood at -$1.6 million in 2022, then tumbled by 44.26% to -$2.3 million in 2023, then fell by 25.79% to -$2.9 million in 2024, then grew by 22.19% to -$2.3 million in 2025.
- Its Operating Income was -$2.3 million in Q3 2025, compared to -$2.5 million in Q2 2025 and -$2.6 million in Q1 2025.